Compounds > n-succinimidyl 8-((4'-fluorobenzyl)amino)suberate
Page last updated: 2024-12-07

n-succinimidyl 8-((4'-fluorobenzyl)amino)suberate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-succinimidyl 8-((4'-fluorobenzyl)amino)suberate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID131431
MeSH IDM0189019

Synonyms (7)

Synonym
n-succinimidyl 8-((4'-fluorobenzyl)amino)suberate
131865-53-7
octanamide, 8-((2,5-dioxo-1-pyrrolidinyl)oxy)-n-((4-fluorophenyl)methyl)-8-oxo-
sfbs
(2,5-dioxopyrrolidin-1-yl) 8-[(4-fluorophenyl)methylamino]-8-oxooctanoate
DTXSID30157238
n-succinimidyl 8-((4/'-fluorobenzyl)amino)suberate

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" However, owing to the short half-life of the radiolabeled CO, it can only be used in centers equipped with a cyclotron."( Erythrocytes labeled with [(18) F]SFB as an alternative to radioactive CO for quantification of blood volume with PET.
Abad, S; Gispert, JD; Herance, JR; Pareto, D; Rojas, S; Torrent, È; Victor, VM, )		0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.42 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (25.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (75.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
ConditionIndicatedRelationship StrengthStudiesTrials
Chronic Kidney Diseases
[description not available]		04.2190
Fungal Diseases
[description not available]		04.2190
Pericementitis
[description not available]		04.2190
Sinus Infections
[description not available]		04.2190
Diabetes Mellitus
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.		04.2190
Mycoses
Diseases caused by FUNGI.		04.2190
Periodontitis
Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology)		04.2190
Sinusitis
Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES.		04.2190
Renal Insufficiency, Chronic
Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)		04.2190
HPV Infection
[description not available]		02.610
Cancer of Oropharnyx
[description not available]		02.610
Oropharyngeal Neoplasms
Tumors or cancer of the OROPHARYNX.		02.610
Papillomavirus Infections
Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.		02.610